Modeling stroke management: a qualitative review of cost-effectiveness analyses

被引：0
|
作者：
Chantal Guilhaume
Delphine Saragoussi
John Cochran
Clément François
Mondher Toumi
机构：
[1] H. Lundbeck A/S,Global Outcomes Research Division
[2] Université de Lyon I (MA2D),undefined
来源：
The European Journal of Health Economics | 2010年 / 11卷
关键词：
Cost-effectiveness analysis; Decision analytic model; Disease management; Markov model; Pharmacoeconomic model; Stroke; I18;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：419 / 426
页数：7
相关论文
共 50 条
  • [31] REHABILITATION COST-EFFECTIVENESS OF STROKE
    BLACKBEARD, RR
    SEEMAN, HMI
    NEW ZEALAND MEDICAL JOURNAL, 1990, 103 (885) : 109 - 109
  • [32] Cost-effectiveness in stroke rehab
    Kane, K
    Andary, MT
    Turk, M
    Goldberg, G
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1996, 77 (05): : 521 - 521
  • [33] Cost-effectiveness of stroke prevention
    Ebrahim, S
    BRITISH MEDICAL BULLETIN, 2000, 56 (02) : 557 - 570
  • [34] Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review
    Grochtdreis, Thomas
    Koenig, Hans-Helmut
    Dobruschkin, Alexander
    von Amsberg, Gunhild
    Dams, Judith
    PLOS ONE, 2018, 13 (12):
  • [35] A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment
    Yuen, Sydney C.
    Amaefule, Adaeze Q.
    Kim, Hannah H.
    Owoo, Breanna-Verissa
    Gorman, Emily F.
    Mattingly, T. Joseph I. I. I. I.
    PHARMACOECONOMICS-OPEN, 2022, 6 (01) : 9 - 19
  • [36] A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis
    Mickaël Hiligsmann
    Silvia M. Evers
    Wafa Ben Sedrine
    John A. Kanis
    Bram Ramaekers
    Jean-Yves Reginster
    Stuart Silverman
    Caroline E. Wyers
    Annelies Boonen
    PharmacoEconomics, 2015, 33 : 205 - 224
  • [37] An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
    Nannan Li
    Dennis Cornelissen
    Stuart Silverman
    Daniel Pinto
    Lei Si
    Ingrid Kremer
    Sandrine Bours
    Robin de Bot
    Annelies Boonen
    Silvia Evers
    Joop van den Bergh
    Jean-Yves Reginster
    Mickaël Hiligsmann
    PharmacoEconomics, 2021, 39 : 181 - 209
  • [38] Cost-effectiveness analyses of TNF antagonists in rheumatoid arthritis: A review
    Bansback, N
    Regier, D
    Ara, R
    Brenan, A
    Shojania, K
    Esdaile, J
    Anis, A
    Marra, C
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S510 - S510
  • [39] Cost-Effectiveness Analyses in Orthopaedic Sports Medicine: A Systematic Review
    Nwachukwu, Benedict U.
    Schairer, William W.
    Bernstein, Jaime L.
    Dodwell, Emily R.
    Marx, Robert G.
    Allen, Answorth A.
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2015, 43 (06): : 1530 - 1537
  • [40] A REVIEW OF COST-EFFECTIVENESS ANALYSES FOR ANEMIA IN CHRONIC KIDNEY DISEASE
    Lavelle, Tara
    Michalopoulos, Steven
    Margaretos, Nikki
    Berklein, Flora
    Shafai, Gigi
    Bozas, Ana
    Sanon, Myrlene
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 707 - 707
12345